Skip to main content
Press Release

Durham Clinician Receives Active Prison Sentence for Fraudulently Obtaining Suboxone

For Immediate Release
U.S. Attorney's Office, Middle District of North Carolina

GREENSBORO, N.C. B A Durham-based clinician was sentenced today in federal court in Greensboro on charges that he used the DEA registration number of another person to acquire suboxone, announced United States Attorney Matthew G.T. Martin of the Middle District of North Carolina.

BASIL DERRICK HALLIDAY, age 57, a resident of Rougemont, North Carolina, was sentenced to a five month term of imprisonment by Senior United States District Judge N. Carlton Tilley, Jr. The term will run consecutive to another five month term imposed because HALLIDAY committed the drug offense while on probation for a 2013 federal conviction for embezzlement from a government agency. In addition to prison time, HALLIDAY was ordered to serve 31 months of supervised release and to pay a special assessment of $500.00. HALLIDAY was convicted of the current charges after a two-day trial in March 2019.

In December 2013, a Diversion Investigator (DI) with the Drug Enforcement Administration received a complaint that HALLIDAY, the President and Owner of Adaptive Integrated Methods (AIM), a drug addiction and mental health treatment clinic, was improperly dispensing suboxone (buprenorphone), a Schedule III controlled substance. In furtherance of the investigation, the DI obtained numerous invoices from Clinic Pharmacy documenting HALLIDAY’s purchases of suboxone. HALLIDAY, however, is not a physician and does not have a license to dispense suboxone or other controlled substances. The pharmacy invoices noted the ordering physician was S.J., and included S.J.’s DEA registration number. S.J. , however, did not authorize the purchases of suboxone.

“We are pleased that the Court ordered active time for this defendant. I hope it sends a strong message about illegally distributing legal drugs. We must stop the flow of opioids to the street. I commend DEA and AUSAs DeFranco and DuPre for their excellent work,” said U.S. Attorney Martin.

The case was investigated by the United States Drug Enforcement Administration. The case was prosecuted by Assistant United States Attorneys Michael A. DeFranco and Nicole R. DuPre.


Updated August 19, 2019